PRIMESTRIPS®

Information on this site is for informational purposes only and is not intended as a substitute for medical advice from a physician or other qualified healthcare professional. PrimeStrips™ content should not be used for diagnosing or treating any health condition, disease, or for prescribing medication. Always read all product information carefully. If you have or suspect a medical condition, please consult your healthcare provider.


New subscribers only. Valid on first PrimeStrips™ subscription order. One per customer. Limited time.

Clinically Studied Ingredients & Formats

PrimeStrips™ formulations are supported by multiple clinical and observational studies, including:

• Triple-blind, randomized, placebo-controlled clinical trial
  Conducted over 12 weeks in 105 healthy adults (ages 20–59), evaluating nutrient biomarkers and microbiome-related markers.
  
  
• Double-blind, randomized, placebo-controlled crossover study
  A 2-week trial in 20 active adults (ages 19–37) assessing nutrient intake gaps and microbiome-related indicators.
  
  
• Double-blind, randomized, placebo-controlled crossover study
  A 4-week evaluation in 24 healthy adults with occasional digestive discomfort (ages 26–59), focusing on nutrient intake gaps and gut-related assessments.
  
  
• Double-blind, randomized, placebo-controlled crossover study
  An 8-hour bioavailability assessment in 16 healthy adults (ages 18–42) examining nutrient absorption markers.
  
  Third-party, single-arm observational study
  
  A 3-month study of 104 healthy adults (ages 25–59) evaluating self-reported experience and satisfaction with PrimeStrips™ formulations.
  
  
  
  PrimeStrips™ formulations and delivery formats are supported by multiple clinical and third-party studies conducted in healthy adult populations, including:
  
  
• Triple-blind, randomized, placebo-controlled clinical trial
  12-week evaluation in 105 healthy adults (ages 20–59), assessing nutrient biomarkers and microbiome-related measures.
  
  
• Double-blind, randomized, placebo-controlled crossover trial
  2-week study in 20 active adults (ages 19–37) examining nutrient intake gaps and microbiome indicators.
  
  
• Double-blind, randomized, placebo-controlled crossover trial
  4-week assessment in 24 healthy adults with occasional digestive discomfort (ages 26–59), evaluating nutrient intake gaps and gut-related measures.
  
  
• Double-blind, randomized, placebo-controlled crossover trial
  Short-term bioavailability assessment in 16 healthy adults (ages 18–42).
  
  

Third-party observational study

3-month evaluation of 104 healthy adults (ages 25–59) assessing self-reported experience and satisfaction with PrimeStrips™.

Actual Packaging May Vary